boric acid + lactobacillus gasseri + lactobacillus rhamnosus

This drug is a vaginal combination therapy consisting of boric acid and two probiotic bacterial strains, *Lactobacillus gasseri* and *Lactobacillus rhamnosus*. Boric acid serves as a mild antiseptic and antifungal agent, particularly useful for recurrent or resistant vulvovaginal candidiasis. The lactobacilli strains are intended to recolonize the vaginal environment, producing lactic acid to maintain a low pH and inhibiting the growth of pathogens like *Gardnerella vaginalis* and *Candida* species. Developed by Laboratorios Ordesa, the formulation is delivered via vaginal capsules and has been evaluated in pilot clinical trials for the treatment of bacterial vaginosis and vaginal candidiasis.

Other names

boric acid + probiotics